Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells

Cancer Immunology, Immunotherapy

Volumn 53, Issue 11, 2004, Pages 978-986

  Dadabayev, A R ^a   Sandel, M H ^a   Menon, A G ^a   Morreau, H ^a   Melief, C J M ^a   Offringa, R ^a   Van Der Burg, S H ^a   Rhijn, C Janssen Van ^a   Ensink, N G ^a   Tollenaar, R A E M ^a   Van De Velde, C J H ^a   Kuppen, P J K ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Colorectal cancer; Dendritic cells; S 100 protein; Tumor infiltrating leukocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN CLASS 2; PROTEIN S 100;

ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; CANCER SURVIVAL; CELL SURVIVAL; COLORECTAL CANCER; DENDRITIC CELL; EPITHELIUM CELL; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; STROMA CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR LOCALIZATION;

ADULT; AGED; ANTIGEN-PRESENTING CELLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DENDRITIC CELLS; DISEASE-FREE SURVIVAL; EPITHELIUM; FEMALE; FOLLOW-UP STUDIES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; LYMPHOCYTES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; S100 PROTEINS; TIME FACTORS; TREATMENT OUTCOME;

EID: 5644255722     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-004-0548-2     Document Type: Article

References (25)

1. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811
2. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245-252
3. Bell D, Young JW, Banchereau J (1999) Dendritic cells. Adv Immunol 72:255-324
4. Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271-296
5. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20:621-667
6. Alavaikko MJ, Blanco G, Aine R, Lehtinen T, Fellbaum C, Taskinen PJ, Sarpola A, Hansmann ML (1994) Follicular dendritic cells have prognostic relevance in Hodgkin's disease. Am J Clin Pathol 101:761-767
7. Ambe K, M Mori, Enjoji M (1989) S-100 protein-positive dendritic cells in colorectal adenocarcinomas: distribution and relation to the clinical prognosis. Cancer 63:496-503
8. Bethwaite PB, Holloway LJ, Thornton A, Delahunt B (1996) Infiltration by immunocompetent cells in early stage invasive carcinoma of the uterine cervix: a prognostic study. Pathology 28:321-327
9. Furihata M, Ohtsuki Y, Ido E, lwata J, Sonobe H, Araki K, Ogoshi S, Ohmori K (1992) HLA-DR antigen- and S-100 protein-positive dendritic cells in esophageal squamous cell carcinoma-their distribution in relation to prognosis. Virchows Arch B Cell Pathol Incl Mol Pathol 61:409-414
10. Giannini A, Bianchi S, Messerini L, Gallo O, Gallina E, Asprella LG, Olmi P, Zampi G (1991) Prognostic significance of accessory cells and lymphocytes in nasopharyngeal carcinoma. Pathol Res Pract 187:496-502
11. Inoue K, Furihata M, Ohtsuki Y, Fujita Y (1993) Distribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis. Virchows Arch A Pathol Anat Histopathol 422:351-355
12. Ishigami S, Natsugoe S, Tokuda K, Nakajo A, Xiangming C, Iwashige H, Aridome K, Hokita S, Aikou T (2000) Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer. Cancer Lett 159:103-108
13. Mori M, Ambe K, Adachi Y, Yakeishi Y, Nakamura K, Hachitanda Y, Enjoji M, Sugimachi K (1988) Prognostic value of immunohistochemically identified CEA, SC, AFP, and S-100 protein-positive cells in gastric carcinoma. Cancer 62:534-540
14. Papla B, Dubiel-Bigaj M, Stachura J (1988) Dendritic cells in bronchial adenocarcinoma. Folia Histochem Cytobiol 26:99-103
15. Reichert TE, Scheuer C, Day R, Wagner W, Whiteside TL (2001) The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer 91:2136-2147
16. Schroder S, Schwarz W, Rehpenning W, Loning T, Bocker W (1988) Dendritic/Langerhans cells and prognosis in patients with papillary thyroid carcinomas. Immunocytochemical study of 106 thyroid neoplasms correlated to follow-up data. Am J Clin Pathol 89:295-300
17. Zeid NA, Muller HK (1993) S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology 25:338-343
18. Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58:3491-3494
19. Suzuki A, Masuda A, Nagata H, Kameoka S, Kikawada Y, Yamakawa M, Kasajima T (2002) Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma. J Pathol 196:37-43
20. Menon AG, Fleuren GJ, Alphenaar EA, Jonges LE, Janssen Van Rhijn CM, Ensink NG, Putter H, Tollenaar RA, van de Velde CJ, Kuppen PJ (2003) A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer. Cancer Immunol Immunother 52:121-126
21. Schwaab T, Weiss JE, Schned AR, Barth RJ Jr (2001) Dendritic cell infiltration in colon cancer. J Immunother 24:130-137
22. Jass JR, Ajioka Y, Allen JP, Chan YF, Cohen RJ, Nixon JM, Radojkovic M, Restall AP, Stables SR, Zwi LJ (1996) Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology 28:543-548
23. LaSalle JM, Ota K, Hafler DA (1991) Presentation of autoantigen by human T cells. J Immunol 147:774-780
24. Nakayama Y, Inoue Y, Minagawa N, Katsuki T, Nagashima N, Onitsuka K, Tsurudome Y, Sako T, Hirata K, Nagata N, Itoh H (2003) Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancer. Anticancer Res 23:4423-4426
25. Tollenaar RA, van Krieken JH, van Slooten HJ, Bruinvels DJ, Nelemans KM, van den Broek LJ, Hermans J, van Dierendonck JH (1998) Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance. Br J Cancer 77:1842-1847